Asterias Biotherapeutics Inc (AST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 116 | 109 | 478 | 28 | 1,688 |
| Cost of Goods | 57 | 57 | 63 | 13 | 81 |
| Gross Profit | 59 | 52 | 415 | 15 | 1,607 |
| Operating Expenses | 5,477 | 5,661 | 5,601 | 8,576 | 8,751 |
| Operating Income | -5,361 | -5,552 | -5,123 | -8,548 | -7,063 |
| Interest Expense | 88 | 95 | 106 | 114 | 112 |
| Other Income | 995 | -1,335 | 2,917 | 2,114 | 366 |
| Pre-tax Income | -4,454 | -6,982 | -2,312 | -6,548 | -6,809 |
| Net Income Continuous | -4,454 | -6,982 | -2,312 | -6,548 | -6,809 |
| Net Income | $-4,454 | $-6,982 | $-2,312 | $-6,548 | $-6,809 |
| EPS Basic Total Ops | -0.08 | -0.13 | -0.04 | -0.11 | -0.14 |
| EPS Basic Continuous Ops | -0.08 | -0.13 | -0.04 | -0.12 | -0.14 |
| EPS Diluted Total Ops | -0.08 | -0.13 | -0.04 | -0.11 | -0.14 |
| EPS Diluted Continuous Ops | -0.08 | -0.13 | -0.04 | -0.12 | -0.14 |
| EPS Diluted Before Non-Recurring Items | -0.08 | -0.10 | -0.09 | -0.12 | -0.15 |
| EBITDA(a) | $-4,442 | $-4,629 | $-4,190 | $-7,606 | $-6,107 |